ITEM METADATA RECORD
Title: Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
Authors: Sitbon, O × McLaughlin, V V Badesch, D B Barst, R J Black, C Galiè, N Humbert, M Rainisio, M Rubin, L J Simonneau, G #
Contributors: Delcroix, Marion
Issue Date: Dec-2005
Publisher: British Medical Association
Series Title: Thorax vol:60 issue:12 pages:1025-1030
Abstract: The oral dual endothelin receptor antagonist bosentan improves exercise capacity and delays clinical worsening in patients with pulmonary arterial hypertension, but its use could delay starting intravenous epoprostenol, a life saving treatment.
Publication status: published
KU Leuven publication type: IT
Appears in Collections: Pneumology
× corresponding author
# (joint) last author
Files in This Item:
There are no files associated with this item.
Request a copy
All items in Lirias are protected by copyright, with all rights reserved.
Web of science